Metabolic Bone Disease in Pediatric Patients with Short Bowel Syndrome

Metabolic bone disease (MBD) is a known complication of short bowel syndrome (SBS), with a high prevalence in both pediatric and adult populations. MBD includes various conditions that disrupt skeletal homeostasis, such as rickets, osteomalacia, and osteoporosis. The pathogenesis of MBD is multifactorial, regardless of the underlying cause of SBS. When MBD is suspected, it is important to conduct laboratory evaluations to guide proper diagnosis and treatment. Dual-energy X-ray absorptiometry (DXA) is the preferred imaging modality for assessing MBD in routine clinical care. Early and accurate diagnosis and treatment of MBD in pediatric patients with SBS are essential to support growth and development and prevent fractures and metabolic complications. Using the best evidence available, this article aims to review the pathophysiology, diagnosis, and current management of MBD in pediatric patients with SBS.